Best Healthcare Companies in Shandong, China
The 60 best Healthcare companies in Shandong, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Luoxin Pharmaceutical Group.
Ranked: Best Healthcare companies in Shandong
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Luoxin Pharmaceutical Group Developer and manufacturer of pharmaceutical products | $301M | — | Acquired | — | 2006 | Apple iCloud MailWindows ServerMicrosoft ASP.NET+3 | — | — |
| 2 | Shandong Xuanzhu Pharmaceutical Technology Developer of therapies for treating cardiovascular diseases, cancer, and diabetes | $210M | 54 mo ago | Series B | Haigui CEO | 2002 | — | — | — |
| 3 | MabPlex CDMO offering biologics development and manufacturing services | $130M | 73 mo ago | Series B | — | 2013 | — | 11 patents ADC linker chemistry and conjugation processes for SN‑38 and binary toxin payloads | 1 partnership |
| 4 | Shandong Freda Pharmaceutical Group R&D company manufacturing drugs for multiple therapeutic areas | $116M | 54 mo ago | Series D | Ling Peixue Founder | 1991 | — | — | — |
| 5 | Rongzhi Biotechnology Manufacturer of life science analytical instruments and consumables | $14M | 82 mo ago | Series D | — | 2013 | — | — | — |
| 6 | EnsiliTech CDMO focused on antibodies, vaccines, and other therapeutics drugs development services | $1M | 10 mo ago | Seed | Asel Sartbaeva CEO | 2022 | Cart FunctionalitySquarespace CommerceSquarespace+15 | — | 4 awards |
| 7 | chjzh.com Standalone pharmacy | $1M | 166 mo ago | Deadpooled | — | 2008 | — | — | — |
| 8 | Shandong Hualian Medical Technology Provider of big data and software development services for biopharma industry | — | 39 mo ago | Seed | Zhang Ye CEO | 2018 | — | — | — |
Top 12 Healthcare companies in Shandong
#1
Seed · Shandong · founded 2022 · 7 employees$1.5Mraised▾
CDMO focused on antibodies, vaccines, and other therapeutics drugs development services
- Aug 2025Seed$6M
- Jan 2023Seed$1.5M
#2
Series B · Jinan, Shandong · founded 2002$209.7Mraised▾
Shandong Xuanzhu Pharmaceutical Technology is a subsidiary of Sihuan Pharmaceutical Holdings. They are developing therapies for treating cardiovascular diseases, cancer, and diabetes. Their lead candidate XZP - 5491 is used to treat cancer. It is an ERBB 2 (epidermal growth factor receptor) receptor, antagonist. Other candidates are mostly in phase I clinical trials. They also offer development services for APIs and intermediates such as process development, scale-up, synthesis, etc.
- Dec 2021Series B$94.1M
- Aug 2020Series A$115.5M
#3
Series D · Jinan, Shandong · founded 1991$115.9Mraised▾
R&D company manufacturing drugs for multiple therapeutic areas
- Dec 2021Series D$115.9M
#4
Series B · Yantai, Shandong · founded 2013 · 667 employees$130Mraised▾
MabPlex offers biologics development and manufacturing services. They are capable of offering services for the development and GMP manufacturing of ADC(Antibody Drug Conjugates), mammalian cell-line based APIs and biologics. They also offer GMP Cell banking, MAb generation, protein characterization services, formulation, lyophilization fill/finish for ADCs, fusion proteins MAbs and final product packaging. Quality Assurance & Control and regulatory services (which they claim to be compliant with FDA, EMA, and CFDA) are also offered by MabPlex.
- Jun 2020Series B$71M
- Jan 2019Series A$59M
#5
Acquired · Linyi, Shandong · founded 2006 · 6000 employees$301Mraised▾
Developer and manufacturer of pharmaceutical products. This entity engages in the research, development, production, and distribution of a diverse portfolio of pharmaceutical products across various therapeutic areas, including gastroenterology, pediatrics, respiratory, oncology, and more. The company operates a robust research and development platform, focusing on both innovative and established drug formulations. It maintains a network for sales and distribution, ensuring market access for its products. The organization also has a dedicated focus on maintaining high standards in drug safety and vigilance.
#6
Series D · Qingdao, Shandong · founded 2013 · 9 employees$14Mraised▾
Developer of rapid genetic and microbial protein analysis instruments used in various fields. The company specializes in the research and development of time of flight mass spectrometer and microfluidics useful for microbial and gene sequencing analysis, providing extensive technological support to the food safety, disease control and medical fields.
- Aug 2019Series D$14M
- Mar 2019Series B—
- Mar 2019Series C—
#7
Deadpooled · Dezhou, Shandong · founded 2008 · 80 employees$1Mraised▾
Standalone pharmacy
- Aug 2012Seed$1M
#8
Seed · Jinan, Shandong · founded 2018—raised▾
Provider and developer of big data and blockchain software designed for healthcare data. The company focuses on research platforms including monitoring system, healthcare data management system and data trading system, enabling clients with healthcare data software.
- Mar 2023Angel—
#9
Series A · Qingdao, Shandong—raised▾
Provider of protein drugs development services
#10
Series A · Jinan, Shandong · founded 2003 · 523 employees—raised▾
Developer and manufacturer of biological and medical products. The company's products are designed for surgery, neurosurgery, cardiovascular and tumor intervention, providing medical industry users with advanced medical equipment.
#11
Public · Jining, Shandong · founded 2008 · 242 employees—raised▾
Manufacturer of stevia-based sweeteners and related products. It produces various grades and forms of stevia for food and beverage applications, along with other nutraceutical products. The company utilizes an integrated global organization for sourcing and production, working closely with suppliers to maintain raw material quality and achieve certifications such as organic, kosher, Halal, and GRAS. A dedicated research and development team enables product customization to meet client specifications. The company's focus is on providing high-quality, taste-optimized stevia products.
- Aug 2012Post IPO—
#12
Series A · Heze, Shandong · founded 2001 · 8491 employees—raised▾
Manufacturer of patent medicine focused on cardiovascular and traditional Chinese medicine. The company develops and produces pharmaceutical products within the cardiovascular therapeutic area. It also focuses on traditional Chinese medicine. The company’s offerings include gynecological and urological medicines.
- Jan 2011Series A—
- Jun 2010Series A—
- Jan 2008Series A—
Funding & investor landscape
Beijing Fupu Daohe Investment Management1 roundsNotable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.